Equity
Total Liabilities & Equity
Thermo Fisher Scientific Total Liabilities & Equity increased by 2.7% to $113.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.4%, from $99.04B to $113.28B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 9.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase indicates the expansion of the company's asset base through debt or equity financing.
Detailed definition
This represents the sum of all liabilities and total stockholders' equity, which must equal the total assets of the comp...
Peer comparison
Universal accounting metric; must equal total assets for all companies under GAAP/IFRS.
Metric ID:
total_liabilities_and_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.70B | $73.60B | $95.12B | $92.75B | $90.58B | $90.54B | $97.15B | $94.66B | $94.11B | $97.06B | $98.73B | $97.10B | $98.50B | $100.36B | $97.32B | $99.04B | $101.23B | $103.02B | $110.34B | $113.28B |
| QoQ Change | — | +8.7% | +29.2% | -2.5% | -2.3% | -0.0% | +7.3% | -2.6% | -0.6% | +3.1% | +1.7% | -1.7% | +1.4% | +1.9% | -3.0% | +1.8% | +2.2% | +1.8% | +7.1% | +2.7% |
| YoY Change | — | — | — | — | +33.8% | +23.0% | +2.1% | +2.1% | +3.9% | +7.2% | +1.6% | +2.6% | +4.7% | +3.4% | -1.4% | +2.0% | +2.8% | +2.6% | +13.4% | +14.4% |
Range$67.70B – $113.28B
CAGR+11.4%
Avg YoY Growth+7.4%
Median YoY Growth+3.1%
Current Streak5 quarters growth
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's total liabilities & equity?
- Thermo Fisher Scientific (TMO) reported total liabilities & equity of $113.28B in Q1 2026.
- How has Thermo Fisher Scientific's total liabilities & equity changed year-over-year?
- Thermo Fisher Scientific's total liabilities & equity increased by 14.4% year-over-year, from $99.04B to $113.28B.
- What is the long-term trend for Thermo Fisher Scientific's total liabilities & equity?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's total liabilities & equity has grown at a 9.8% compound annual growth rate (CAGR), from $69.05B to $110.34B.
- What does total liabilities & equity mean?
- The total amount of debt and equity used to finance the company's assets.